BioMarin Pharmaceutical, Inc. (NASDAQ:BMRN)

CAPS Rating: 3 out of 5

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.

Recs

1
Player Avatar Lcrazylegs84 (< 20) Submitted: 10/1/2011 12:47:29 AM : Outperform Start Price: $31.70 BMRN Score: +4.46

Up Up and away

Report this Post Reply

Featured Broker Partners


Advertisement